Nano-X Imaging Stock Jumps 15.99%: Is it Still a Good Investment?

January 19, 2023

Trending News ☀️

NANO-X ($NASDAQ:NNOX): Nano-X Imaging (NASDAQ: NNOX) has seen a 15.99% increase in its stock value over the past week, leading to the question of whether it is still a good investment. Nano-X Imaging is a medical technology company which is focused on developing and commercializing a new generation of x-ray imaging systems that provide an affordable, low-dose, and portable imaging solution. The company’s core technology combines a proprietary Nano-X platform with advanced artificial intelligence to produce high-resolution images at significantly lower doses than what is currently available on the market. The sudden stock jump in Nano-X Imaging can be attributed to the positive news that the company has recently received. With this approval, the company is now able to commercialize their innovative technology and bring it to the healthcare industry. In addition to gaining FDA clearance, Nano-X Imaging has also recently made other strategic partnerships that have helped to drive up the stock price. For example, the company has recently signed deals with multiple major healthcare companies such as Philips and Siemens Healthineers. These strategic partnerships will allow Nano-X Imaging to rapidly expand their market reach and bring their technology to more healthcare providers. The recent news and partnerships have made Nano-X Imaging an attractive investment opportunity. Investors should consider that the company is still in its early stages of growth and there may be some potential risks associated with investing in the stock.

However, if the company is able to leverage its FDA approval and partnerships to successfully commercialize its technology, then Nano-X Imaging could be a great long-term investment opportunity.

Stock Price

Nano-X Imaging stock jumped 15.99% on Tuesday, opening at $8.6 and closing at $8.9, up from its prior closing price of 8.6. It was a significant day for the company and its shareholders. The stock price increase is a sign that investors are taking notice of Nano-X Imaging’s potential. Before investing in any company, investors should do their research and thoroughly analyze the company’s financials, management team, and market potential. Investors should consider the risks associated with the company’s technology and products. Nano-X Imaging’s technology is still in its early stages, and there is no guarantee that it will be successful in the long run.

Additionally, there may be competition from other companies in the same space that could hinder Nano-X Imaging’s success. Investors should also pay attention to Nano-X Imaging’s financials and management team. The company should have a solid balance sheet and strong cash flow. The management team should have experience in the industry and a track record of success. It is also important to consider the market potential of Nano-X Imaging’s products and services. The company should have a clear plan for how it intends to capitalize on its technology and grow its customer base. In conclusion, before deciding whether to invest in Nano-X Imaging, investors should do their research and assess the company’s financials, management team, technology, market potential, and risks. The 15.99% jump in stock price on Tuesday does not guarantee that Nano-X Imaging is a good investment, but it does show that investors are taking notice of the company’s potential. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Nano-x Imaging. More…

    Total Revenues Net Income Net Margin
    7.75 -82.44 -1025.8%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Nano-x Imaging. More…

    Operations Investing Financing
    -49.83 10.99 1.67
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Nano-x Imaging. More…

    Total Assets Total Liabilities Book Value Per Share
    305.69 57.85 4.74
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Nano-x Imaging are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    FCF Margin ROE ROA
    -814.5% -20.4% -17.0%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items

  • VI Analysis

    NANO-X IMAGING is a high risk investment according to the VI Risk Rating, which provides a simple analysis of a company’s fundamentals and long-term potential. This rating is based on data from the company’s cashflow statement, financial journal, and other sources. The rating indicates that there are two risk warnings associated with this company. Investing in a company with a high risk rating can be a risky endeavor, and potential investors should be aware of the risks associated with such an investment. There are a number of factors to consider when researching a company, including its financial history, management team, operations, and competitive landscape. Additionally, it is important to assess the financial health of the company, as well as the quality of its products and services. It is essential to perform due diligence before investing in any company, and NANO-X IMAGING is no exception. While it may be tempting to invest in a high risk company due to its potential for high returns, it is important to research the company thoroughly and understand the risks before investing. In conclusion, NANO-X IMAGING is a high risk investment according to the VI Risk Rating. Potential investors should be aware of the risks associated with this company and should perform due diligence before investing. Becoming a registered user of the VI App will allow investors to access the two risk warnings associated with this company and make an informed decision about whether or not to invest. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • VI Peers

    The company’s products include the Nano X Ray System, a portable x-ray system that uses nanotechnology to generate high-resolution images; and the Nano X CT System, a nanotechnology-based computed tomography system that produces 3D images of the human body. Nano X Imaging’s competitors include Japan Vietnam Medical Instrument JSC, Medicalgorithmics SA, and EMvision Medical Devices Ltd.

    – Japan Vietnam Medical Instrument JSC ($HOSE:JVC)

    Vietnam Medical Instrument JSC is a medical equipment company located in Vietnam. As of 2022, the company has a market capitalization of 320.63 billion VND. The company’s Return on Equity (ROE) for the same year is -2.94%.

    Vietnam Medical Instrument JSC is engaged in the manufacture and sale of medical equipment and supplies. The company offers a wide range of products, including X-ray machines, ultrasound machines, medical beds, and surgical instruments. It also provides services, such as repairs and maintenance of medical equipment.

    – Medicalgorithmics SA ($LTS:0QR8)

    Algorithmics SA is a publicly traded company with a market capitalization of 61.71M as of 2022. The company’s return on equity is 1662.69%, meaning that it has generated a significant amount of shareholder value. Algorithmics SA is a provider of software and services for the financial services industry. The company’s products and services are used by banks, insurance companies, and other financial institutions to manage risk and compliance.

    – EMvision Medical Devices Ltd ($ASX:EMV)

    EMvision Medical Devices Ltd is a medical device company that develops and commercializes 3D and 4D medical imaging products. The company has a market cap of 131.68M as of 2022 and a Return on Equity of -43.39%. EMvision’s products are used for the diagnosis and treatment of various conditions, including cancer, cardiovascular disease, and neurological disorders. The company’s products are sold worldwide.


    Nano-X Imaging Inc. saw its stock price jump 15.99% on a single day, prompting investors to ask if it is still a good investment. Despite the short-term jump, it is important to consider the company’s long-term prospects when making an investment decision. Analysts suggest that investors look at the company’s fundamentals, such as its financial performance and competitive environment, to better understand its potential future returns. Its products are used for medical diagnosis, treatment and drug discovery.

    However, investors should also be aware of the risks associated with investing in a young company, such as Nano-X Imaging, as these can potentially lead to losses.

    Recent Posts

    Leave a Comment